United States Securities and Exchange Commission Form

Total Page:16

File Type:pdf, Size:1020Kb

United States Securities and Exchange Commission Form UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ፤ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Fiscal Year Ended March 2, 2013 OR អ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission File Number 1-5742 RITE AID CORPORATION (Exact name of registrant as specified in its charter) Delaware 23-1614034 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 30 Hunter Lane, Camp Hill, Pennsylvania 17011 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (717) 761-2633 Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, $1.00 par value New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ፤ No អ Indicate by check mark if the registrant is not required to file reports pursuant to section 13 or section 15(d) of the Exchange Act. Yes អ No ፤ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ፤ No អ Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes ፤ No អ Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ፤ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of ‘‘Accelerated Filer’’ and ‘‘Large Accelerated Filer’’ in Rule 12b-2 of the Exchange Act. Large Accelerated Filer ፤ Accelerated Filer អ Non-Accelerated Filer អ Smaller reporting company អ (Do not check if a smaller reporting company) Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes អ No ፤ The aggregate market value of the voting and non-voting common stock of the registrant held by non-affiliates of the registrant based on the closing price at which such stock was sold on the New York Stock Exchange on September 1, 2012 was approximately $861,991,122. For purposes of this calculation, executive officers, directors and 5% shareholders are deemed to be affiliates of the registrant. As of April 11, 2013 the registrant had outstanding 904,564,621 shares of common stock, par value $1.00 per share. DOCUMENTS INCORPORATED BY REFERENCE Portions of the proxy statement for the registrant’s annual meeting of stockholders to be held on June 20, 2013 are incorporated by reference into Part III. TABLE OF CONTENTS Page Cautionary Statement Regarding Forward-Looking Statements .......................... 2 PA RT I ITEM 1. Business ..................................................... 3 ITEM 1A. Risk Factors .................................................. 11 ITEM 1B. Unresolved Staff Comments ....................................... 19 ITEM 2. Properties .................................................... 19 ITEM 3. Legal Proceedings .............................................. 21 ITEM 4. Mine Safety Disclosures .......................................... 23 PA RT I I ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities ............................... 23 ITEM 6. Selected Financial Data .......................................... 24 ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations ................................................. 26 ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk ............... 45 ITEM 8. Financial Statements and Supplementary Data ......................... 46 ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure .................................................. 46 ITEM 9A. Controls and Procedures ......................................... 46 ITEM 9B. Other Information .............................................. 49 PART III ITEM 10. Directors, Executive Officers and Corporate Governance .................. ITEM 11. Executive Compensation ......................................... ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters ........................................... ITEM 13. Certain Relationships and Related Transactions, and Director Independence .... ITEM 14. Principal Accountant Fees and Services .............................. PA RT I V ITEM 15. Exhibits and Financial Statement Schedule ............................ 49 SIGNATURES ............................................................ 115 1 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This report, as well as our other public filings or public statements, include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward- looking statements are often identified by terms and phrases such as ‘‘anticipate,’’ ‘‘believe,’’ ‘‘intend,’’ ‘‘estimate,’’ ‘‘expect,’’ ‘‘continue,’’ ‘‘should,’’ ‘‘could,’’ ‘‘may,’’ ‘‘plan,’’ ‘‘project,’’ ‘‘predict,’’ ‘‘will’’ and similar expressions and include references to assumptions and relate to our future prospects, developments and business strategies. Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: • our high level of indebtedness; • our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our senior secured credit facility and other debt agreements; • general economic conditions (including the impact of continued high unemployment and changing consumer behavior), inflation and interest rate movements; • our ability to improve the operating performance of our stores in accordance with our long term strategy; • our ability to maintain or grow prescription count and realize front-end sales growth; • our ability to retain the business we have gained as a result of the Walgreens / Express Scripts dispute which was settled in September 2012; • our ability to hire and retain qualified personnel; • the continued efforts of private and public third party payors to reduce prescription drug reimbursement and encourage mail order and limit access to payor networks; • competitive pricing pressures, including aggressive promotional activity from our competitors; • decisions to close additional stores and distribution centers or undertake additional refinancing activities, which could result in further charges to our operating statement; • our ability to manage expenses and our investment in working capital; • continued consolidation of the drugstore and the pharmacy benefit management industries; • changes in state or federal legislation or regulations, and the continued impact from the ongoing implementation of the Patient Protection and Affordable Care Act as well as other healthcare reform; • the outcome of lawsuits and governmental investigations; • our ability to maintain the listing of our common stock on the New York Stock Exchange (the ‘‘NYSE’’), and the resulting impact on our indebtedness, results of operations and financial condition; and • other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission (the ‘‘SEC’’). We undertake no obligation to update or revise the forward-looking statements included in this report, whether as a result of new information, future events or otherwise, after the date of this report. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. Factors that could cause or contribute to such differences are discussed in the sections entitled ‘‘Risk Factors’’ and ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations—Overview and Factors Affecting Our Future Prospects’’ included in this annual report on Form 10-K. 2 PART I Item 1. Business Overview Rite Aid is the third largest retail drugstore chain in the United States based on both revenues and number of stores. As of March 2, 2013, we operated 4,623 stores in 31 states across the country and in the District of Columbia. In our stores, we sell prescription drugs and a wide assortment of other merchandise, which we call ‘‘front-end’’ products. In fiscal 2013, prescription drug sales accounted for 67.6% of our total sales. We believe that pharmacy operations will continue to represent a significant part of our business due to favorable industry trends,
Recommended publications
  • Come Exhibit with Us
    Store Brands Got The Power Come Exhibit With Us 2011 2010 26.0% 2009 25.0% 2008 23.7% 2007 22.3% 21.2% November 14-16 Chicago Presented by the Private Label Manufacturers Association Store Brands ll across the country, store brands power is driving big increases in store brands sales. A New categories. New merchandising ideas. New package designs. New shelf allocation. Store brands are reaching unheard of levels of consumer popularity and retailer commitment. For manufacturers, store brands power is the power to compete with big national brands in category after category without big advertising budgets and promotion allowances. It’s the power to make a small and medium-size company important to retailers. It’s the power to market your products to millions of consumers. It means new opportunities for your business. Store brands power is growing, too. According to GfK Roper, 57% of all shoppers now say that they purchase store brands frequently, up from 36% ten years ago. Moreover, 9 out of 10 consumers say that store brands are now as good as or better than national brands and one-third of all shoppers expect to buy more store brands in the year ahead. November Got The Power THE SHOW FOR STORE BRANDS MORE THAN PRODUCTS PLMA gives you the chance to show your power. For PLMA’s annual show is more than just products, though. nearly 30 years, PLMA’s Private Label Trade Show has PLMA’s Innovation Hall features the latest software and been the place where retailers and suppliers meet to technology to make business more efficient.
    [Show full text]
  • Page 1 of 239 05-Jun-2019 7:38:44 State of California Dept. of Alcoholic
    05-Jun-2019 State of California Page 1 of 239 7:38:44 Dept. of Alcoholic Beverage Control List of All Surrendered Retail Licenses in MONROVIA District File M Dup Current Type GEO Primary Name DBA Name Type Number I Count Status Status Date Dist Prem Street Address ------ ------------ - -------- ------------- ----------------- -------- ------------------------------------------------------------------- ------------------------------------------------------------------ 20 250606 Y SUREND 02/25/2017 1900 KOJONROJ, PONGPUN DBA: MINI A 1 MART 2 11550 COLIMA RD WHITTIER, CA 90604 61 274544 Y SUREND 04/17/2017 1900 JUAREZ MUNOZ, BARTOLO DBA: CAL TIKI BAR 2 3835 WHITTIER BLVD LOS ANGELES, CA 90023-2430 20 389309 Y SUREND 12/13/2017 1900 BOULOS, LEON MORID DBA: EDDIES MINI MART 2 11236 WHITTIER BLVD WHITTIER, CA 90606 48 427779 Y SUREND 12/04/2015 1900 OCEANS SPORTS BAR INC DBA: OCEANS SPORTS BAR 2 14304-08 TELEGRAPH RD ATTN FREDERICK ALANIS WHITTIER, CA 90604-2905 41 507614 Y SUREND 02/04/2019 1900 GUANGYANG INTERNATIONAL INVESTMENT INC DBA: LITTLE SHEEP MONGOLIAN HOT POT 2 1655 S AZUSA AVE STE E HACIENDA HEIGHTS, CA 91745-3829 21 512694 Y SUREND 04/02/2014 1900 HONG KONG SUPERMARKET OF HACIENDA HEIGHTS,DBA: L HONGTD KONG SUPERMARKET 2 3130 COLIMA RD HACIENDA HEIGHTS, CA 91745-6301 41 520103 Y SUREND 07/24/2018 1900 MAMMA'S BRICK OVEN, INC. DBA: MAMMAS BRICK OVEN PIZZA & PASTA 2 311 S ROSEMEAD BLVD #102-373 PASADENA, CA 91107-4954 47 568538 Y SUREND 09/27/2018 1900 HUASHI GARDEN DBA: HUASHI GARDEN 2 19240 COLIMA RD ROWLAND HEIGHTS, CA 91748-3004 41 571291 Y SUREND 12/08/2018 1900 JANG'S FAMILY CORPORATION DBA: MISONG 2 18438 COLIMA RD STE 107 ROWLAND HEIGHTS, CA 91748-5822 41 571886 Y SUREND 07/16/2018 1900 BOO FACTOR LLC DBA: AMY'S PATIO CAFE 2 900 E ALTADENA DR ALTADENA, CA 91001-2034 21 407121 Y SUREND 06/08/2015 1901 RALPHS GROCERY COMPANY DBA: RALPHS 199 2 345 E MAIN ST ALHAMBRA, CA 91801 05-Jun-2019 State of California Page 2 of 239 7:38:44 Dept.
    [Show full text]
  • Retail Drug Agreement
    RETAIL DRUG AGREEMENT July 15, 2018 - July 17, 2021 between THRIFTY PAYLESS INC. D/B/A RITE AID and UFCW LOCALS 135, 324, 770, 1167, 1428, 1442, and 8GS INDEX ARTICLE 1 - MANAGEMENT RIGHTS .................................................................................................................................. 1 ARTICLE 2 - BARGAINING UNIT .......................................................................................................................................... 1 2.1 UNION RECOGNITION .............................................................................................................................................. 1 2.2 INCLUDED BARGAINING UNIT WORK ................................................................................................................. 2 2.2.1 Current Work ....................................................................................................................................................... 2 2.2.2 Future Work ......................................................................................................................................................... 2 2.2.3 Employee Definitions ........................................................................................................................................... 2 2.2.3.1 Intern Pharmacist .............................................................................................................................................................. 2 2.2.3.2 Drug Clerk .......................................................................................................................................................................
    [Show full text]
  • The Jean Coutu Group (Pjc) Inc
    THE JEAN COUTU GROUP (PJC) INC. ANNUAL INFORMATION FORM Financial year ended May 31, 2002 October 18, 2002 TABLE OF CONTENTS ITEM 1 - INCORPORATION................................................................................................................................... 3 1.1 INCORPORATION OF THE ISSUER ................................................................................................................... 3 1.2 CAPITAL STRUCTURE.................................................................................................................................... 3 1.3 SUBSIDIARIES................................................................................................................................................ 4 ITEM 2 - GENERAL DEVELOPMENT OF THE BUSINESS.............................................................................. 4 2.1 HISTORY AND PROFILE ................................................................................................................................. 4 2.2 PRINCIPAL DEVELOPMENT AND ACQUISITIONS OF THE LAST FIVE YEARS ................................................... 5 ITEM 3 - DESCRIPTION OF ACTIVITIES ........................................................................................................... 6 3.1 FRANCHISING................................................................................................................................................ 6 3.1.1 Franchising Business ....................................................................................................................
    [Show full text]
  • Beverly Hills Living in the City
    city • Measure E’s donations have come briefs • Board wrestles over send- rudy cole • Just What from financially invested firms Page 3 ing lawyers to city meetings Page 5 You Wanted, More Hilton Page 6 ALSO ON THE WEB Beverly Hills www.bhweekly.com Living In The City WeeklySERVING BEVERLY HILLS • BEVERLYWOOD • LOS ANGELES Issue 471 • October 9 - October 15, 2008 HowHow willwill BeverlyBeverly HillsHills bebe impactedimpacted byby thethe unsteadyunsteady economy?economy? OUR 9th Anniversary cover story • page 9 KBeverly High Robbers hit jewelry Finding Some Humor In • • • project of three towers. will reduce the area of their nine-acre photosClass of '88 Reunion Page 4 sbriefstore on Beverly Drive Page 5 rudyTroubling Times,cole Hopefully Page 6 ALSO ON THE WEB Secondly, this is NOT a hotel project that property that is covered by buildings from Beverly Hills www.bhweekly.com adds financial benefits to the city. It is a 67% to 47%. A twenty percent reduction letters condo project that adds huge benefits to is not much when you consider how much WeeklySERVING BEVERLY HILLS • BEVERLYWOOD • LOS ANGELES the developer’s pocket from the quick of the area viewed from the streets will be Issue 470 • October 2 - October 8, 2008 return of their investment upon the sale of covered by concrete and that all three new & the condos. City Council and Planning towers are adjacent to streets. Also, the Living In The City email Commissioners agreed about the benefits Hilton never gives you a sense of how of having an additional luxury hotel in our much green you will actually see from the “Stone and Lawn Signs of the Times” city since we receive a major portion of exterior, not much.
    [Show full text]
  • Overview of Ftc Antitrust Actions in Pharmaceutical Services and Products
    OVERVIEW OF FTC ANTITRUST ACTIONS IN PHARMACEUTICAL SERVICES AND PRODUCTS Health Care Division Bureau of Competition Federal Trade Commission Washington D.C. 20580 Markus H. Meier Assistant Director Bradley S. Albert Deputy Assistant Director Saralisa C. Brau Deputy Assistant Director September 2009 TABLE OF CONTENTS Page I. INTRODUCTION. ........................................................... 1 II. CONDUCT INVOLVING PHARMACEUTICAL SERVICES AND PRODUCTS. 3 A. Monopolization. ...................................................... 3 B. Agreements Not to Compete. ............................................ 8 C. Agreements on Price or Price-Related Terms. 14 D. Agreements to Obstruct Innovative Forms of Health Care Delivery or Financing. 20 E. Illegal Tying and Other Arrangements. .................................... 20 III. PHARMACEUTICAL MERGERS. ........................................... 20 A. Horizontal Mergers Between Direct Competitors. 20 B. Potential Competition Mergers. ......................................... 44 C. Innovation Market Mergers. ............................................ 47 D. Vertical Mergers...................................................... 49 IV. INDUSTRY GUIDANCE STATEMENTS...................................... 50 A. Advisory Opinions. ................................................... 50 B. Citizen Petition to the Food and Drug Administration. 51 V. AMICUS BRIEFS. ......................................................... 51 VI. INDICES. ............................................................
    [Show full text]
  • Pharmacies Participating in 90-Day Extended Network
    Ambetter from Peach State Health Plan: Pharmacies Participating in 90-Day Extended Network City Name Address 1 Zip Code Phone 24-Hour Chain Name ABBEVILLE ABBEVILLE DISCOUNT DRUGS 201 W MAIN ST 310011213 229 467-2221 N LEADER DRUG STORES INC ACWORTH CVS PHARMACY 4595 HWY 92 30102 770 529-9712 N CVS PHARMACY INC ACWORTH CVS PHARMACY 3513 BAKER RD STE 500 30101 770 917-0408 N CVS PHARMACY INC ACWORTH DOLLAR PRESCRIPTION SHOP TOO 2151 CEDARCREST RD 30101 770 672-0846 N THIRD PARTY STATION CP ACWORTH ELDERCARE PHARMACY 4769 S MAIN ST 30101 770 974-4277 N MHA LONG TERM CARE NETWORK ACWORTH KROGER PHARMACY 6199 HIGHWAY 92 30102 770 924-9105 N THE KROGER CO ACWORTH KROGER PHARMACY 1720 MARS HILL RD 30101 770 419-5495 N THE KROGER CO ACWORTH KROGER PHARMACY 3330 COBB PARKWAY 30101 770 975-8776 N THE KROGER CO ACWORTH LACEY DRUG COMPANY 4797 S MAIN ST 301015392 770 974-3131 N ELEVATE PROVIDER NETWORK ACWORTH LACEYS LTC PHCY 4469 LEMON ST 30101 678 236-0400 N GERIMED LTC NETWORK INC ACWORTH PUBLIX PHARMACY #0566 1727 MARS HILL RD 30101 770 218-2426 N PUBLIX SUPER MARKETS INC ACWORTH PUBLIX PHARMACY #0593 3507 BAKER ROAD SUITE 300 30101 770 917-0218 N PUBLIX SUPER MARKETS INC ACWORTH PUBLIX PHARMACY #1096 6110 CEDARCREST ROAD NW 30101 678 439-3446 N PUBLIX SUPER MARKETS INC ACWORTH RED CARPET PHARMACY 3450 COBB PKWY NW STE 110 301018351 770 529-9277 N LEADER DRUG STORES INC ACWORTH RITE AID PHARMACY 11732 3245 COBB PARKWAY 30101 770 974-0936 N RITE AID CORPORATION ACWORTH RITE AID PHARMACY 11733 1775 MARS HILL ROAD 30101 770 919-0882 N RITE AID
    [Show full text]
  • Clinique Now More Accessible Than Ever Famous Brand Arriving at Jean Coutu
    Press Release For Immediate Release Clinique now more accessible than ever Famous brand arriving at Jean Coutu Varennes, Quebec, May 12, 2017 – The Jean Coutu Group (PJC) Inc. (the "Corporation" or the "Jean Coutu Group") announces the arrival of the famous Clinique brand in several of its affiliated stores in Quebec and New Brunswick. From the outset, Clinique has set itself apart through products adapted for every skin concern. In order to reach a wider clientele, of both women and men, the products are now available in most areas of the province (see list). As of now, all the products can also be purchased online at cliniqueproducts.jeancoutu.com. "We are pleased to offer Clinique products, previously available only in large centres, over a wider territory. The implementation will be staggered over three years. 54 stores will carry the brand by August 2017," said Christian Comtois, Senior Manager, Cosmetics at Jean Coutu Group. "As the high end skincare brand in Canada, Clinique is pleased to partner with Jean Coutu, the most admired and respected retailer in Quebec. We are convinced that Clinique’s beauty vision, based on simple routines that give astonishing results, is completely in line with Jean Coutu’s customers throughout the province. We look forward to the future and this important association between two iconic brands," said Artur Klepacz, Brand General Manager at Clinique Canada and LAB SERIES Skincare For Men. A wide range of products Jean Coutu will carry the popular skincare lines such as the famous 3-Step system, Acne Solutions products, the men’s line, the Smart franchise, anti-aging skincare and several recent products.
    [Show full text]
  • Youth Access Tobacco Enforcement Program Annual Report 04-05
    Youth Access Tobacco Enforcement Program Annual Report October 1, 2004 - September 30, 2005 � TobaccoSales To Youth New York State Department of Health Questions or requests for additional copies of this report: New York State Department of Health Bureau of Community Environmental Health & Food Protection Tobacco Enforcement Program Flanigan Square, Room 515 547 River Street Troy, NY 12180-2216 Telephone: (518) 402-7600 or 1 (800) 458-1158, ext. 27600 Fax: (518) 402-7609 This annual report of the New York State Department of Health (NYS DOH) Youth Access Tobacco Enforcement Program is prepared in accordance with Section 1399-kk of the Public Health law and is submitted by the Commissioner of Health to the Governor and the Legislature. ACKNOWLEDGEMENTS Special thanks go to the local health department enforcement officers, the New York City Department of Consumer Affairs and the youth who participated in the access compliance check surveillance initiative. Staff of the New York State Department of Health’s Bureau of Community Environmental Health and Food Protection Tobacco Enforcement Program prepared this report with data provided from the local enforcement officers, other State agencies and programs within the Department of Health. The New York State Department of Health’s Tobacco Control Program and the New York State Education Department supplied information regarding tobacco use and trends among minors. The State Department of Taxation and Finance provided registration and revenue data. The Department of State’s Office of Fire Prevention
    [Show full text]
  • Rite Aid-Walgreens Pharmacy (F.D.)
    Rite Aid-Walgreens Pharmacy (F.D.) Columbia, SC CONFIDENTIAL OFFERING MEMORANDUM TABLE OF CONTENTS Investment Overview 03 Executive Summary Tenant Overview 04 Tenant Overview Location Overview 05 Regional Map 06 Local Map 07 Property View Market Overview 08 Market Analysis 09 Demographics Confidentiality Agreement 10 Disclaimer Furman Capital Advisors, LLC 101 E. Washington Street, Suite 400 Greenville, SC 29601 | 864.235.6855 FurmanCapital.com INVESTMENT OVERVIEW Executive Summary PROPERTY SUMMARY FINANCIAL SUMMARY 7900 Garners Ferry Road Address NOI $336,652 Columbia, SC 29209 Total GLA ±13,813 SF Cap Rate 10% Total Land Size ±1.87 AC List Price $3,366,520 Parcel Number R19105-01-01 Construction Steel frame and brick Year Built 2004 Parking Spaces ±64 INVESTMENT STRENGTHS • Walgreen Boots Alliance (S&P: BBB) guarantees the NNN absolute lease through its acquisition of Rite Aid • WBA (NASDAQ: WBA) has a market cap of $118B • 5+ years remain on lease (Feb 2025) • Signalized hard corner intersection has exposure to over 49,000 VPD • Large, squared-off 1.87 acre parcel offers great potential of redevelopment with dual points of egress/ ingress • ±13,800 SF steel frame and brick building with drive-thru • Built in 2004 • Sub-tenant Family Dollar occupied in February ‘19 3. Rite Aid (dark) | Columbia, SC TENANT OVERVIEW Tenant Summary Rite Aid began in 1962 as Thrift D Discount Center, opening its first store in Scranton, Pennsylvania. After several years of growth, Rite Aid adopted its current name and debuted as a public company in 1968. Ten years after its first store opened, Rite Aid operated 267 locations in 10 states.
    [Show full text]
  • Long Island University Arnold & Marie Schwartz College of Pharmacy And
    Long Island University Arnold & Marie Schwartz College of Pharmacy and Health Sciences 1998-2000 Undergraduate & Graduate Bulletin Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University 75 DeKalb Avenue, Brooklyn, NY 11201-5497 General Information: (718) 488-1000 http://www.liu.edu Admissions: (718) 488-1011 Fax: (718) 797-2399 Email: [email protected] The Arnold & Marie Schwartz College of Pharmacy and Health Sciences Undergraduate & Graduate Bulletin is issued biennially. A schedule of classes is published by the Office of the Registrar for the Fall, Spring and Summer sessions. Notice to Students. Long Island University reserves the right to delete any course described in this publication for any reason and cannot guarantee enrollment into any specific sections of courses. The University also reserves the right to effect any other changes in the curriculum, administration, tuition and fees, program offerings, or any other phase of school activity without notice. The University expects each student to have a knowledge of the information presented in the bulletin and other official publications of the various faculties and campuses pertaining to his/her course of study. For further information or specific degree requirements, prospective students should call the Admissions Office and enrolled students should speak with their advisers. College of Pharmacy and Health Sciences College of Pharmacy and Health Sciences; the Friends LONG ISLAND UNIVERSITY World Program of global education for social change; var - sity and intramural teams in 76 sports; WPBX-FM and WCWP-FM, Long Island’s Public Radio Network; the Long Island University, the United States’ eighth- world-renowned Tilles Center for the Performing Arts; largest private university measured by enrollment, is a and a proud, accomplished group of more than 135,000 multi-campus, doctoral degree-granting institution serving alumni and alumnae.
    [Show full text]
  • Pharmacies Located in North Carolina
    Blue Cross and Blue Shield of North Carolina Limited Network: Pharmacies Located in North Carolina Pharmacy Name Address City State Zip Phone Number 1ST RX PHARMACY 837 N CENTER ST STATESVILLE NC 28677 7048720880 1ST RX PHARMACY INC- GREENBRIAR 308-A MOCKSVILLE HWY STATESVILLE NC 28625 7048786225 A1 PHARMACY AND SURGICAL SUPPLY LLC 124 FOREST HILL RD LEXINGTON NC 27295 3362246500 A2Z HEALTHMART PHARMACY 1408 ARCHDALE DR CHARLOTTE NC 28210 9803550906 ABERDEEN PRESCRIPTION SHOPPE 1389 N SANDHILLS BLVD ABERDEEN NC 28315 9109441313 ADDICTION RECOVERY MEDICAL SERVICES 536 SIGNAL HILL DRIVE EXT STATESVILLE NC 28625 7048181117 ADULT CLINIC AND GERIATRIC CENTER A 25 OFFICE PARK DRIVE JACKSONVILLE NC 28546 9103534878 ADVANCED HOME CARE 4001 PIEDMONT PKWY GREENSBORO NC 27265 3368788950 AKERS PHARMACY INC 1595 E GARRISON BLVD GASTONIA NC 28054 7048653411 ALBEMARLE COMPNDN N PRESCRIPT CNT 944 N FIRST ST ALBEMARLE NC 28001 7049836176 ALBEMARLE PHARMACY 105 YADKIN ST ALBEMARLE NC 28001 7049838222 ALLCARE PHARMACY SERVICES, LLC 5176 NC HIGHWAY 42 W STE H GARNER NC 27529 9199267371 ALLEN DRUG 220 S MAIN ST STANLEY NC 28164 7042634876 ALLEN DRUGS INC 9026 HIGHWAY 17 POLLOCKSVILLE NC 28573 2522245591 ALMANDS DRUG STORE 3621 SUNSET AVE ROCKY MOUNT NC 27804 2524433138 ANDERSON CREEK PHARMACY, INC 6779 OVERHILLS RD SPRING LAKE NC 28390 9104976337 ANGIER DISCOUNT DRUG 253 N RALIEGH STREET ANGIER NC 27501 9196399623 ANSON PHARMACY INC 806 CAMDEN RD WADESBORO NC 28170 7046949358 APEX PHARMACY 904 W WILLIAMS ST APEX NC 27502 9196297146 ARCHDALE DRUG AT CORNERSTONE
    [Show full text]